Our results indicate that SRC kinase activity is elevated in cisplatin-resistant HNSCC, which is consistent with increased ETS-1 levels in multiple cisplatin-resistant HNSCC cell lines. This evidence concerns the gene ETS1 and head and neck squamous cell carcinoma.